Adolescent, young adult leukemia survivors face higher mortality rates than the general population

The long-term survival of adolescent and young adult (AYA) acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) survivors was shorter than that of the general population, and the differences persisted for up to 30 years after diagnosis, according to results published in Cancer Epidemiology, Biomarkers & Prevention.

This article was originally published on MedicalXpress.com

Read More: